Global Biphasic External Defibrillator Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

What is the Biphasic External Defibrillator Market Size and Growth Rate?

• As per Data Bridge Market Research analysis, the biphasic external defibrillator market was valued at USD 132.50 million in 2025 and is projected to reach USD 272.86 million by 2033, growing at a CAGR of 9.45% from 2026 to 2033.
• The market is experiencing steady growth driven by the rising prevalence of cardiovascular diseases and sudden cardiac arrest, increasing deployment of automated external defibrillators (AEDs) in public spaces, continuous technological advancements in biphasic waveform technology, and supportive government initiatives promoting public access defibrillation programs.
• The growing burden of out-of-hospital cardiac arrest, combined with increasing awareness of early defibrillation and expanding installation of AEDs across hospitals, emergency medical services, airports, schools, workplaces, and other public locations, is accelerating market adoption. In addition, improvements in portable device design, real-time CPR feedback, smart connectivity, and user-friendly operation are enhancing emergency response capabilities and encouraging broader deployment of biphasic external defibrillators worldwide.

Market Size & Forecast

• Global Market Value (2025): USD 132.50 Million
• Expected Market Value (2033): USD 272.86 Million
• Forecast CAGR (2026–2033): 9.45%
• Leading Region in 2025: North America
• Fastest Growing Region: Asia Pacific

What are the Major Takeaways of the Biphasic External Defibrillator Market?

• North America dominated the biphasic external defibrillator market with the largest revenue share of 41.9% in 2025, supported by a high prevalence of cardiovascular diseases, favorable public access defibrillation initiatives, and strong adoption of advanced emergency medical technologies.
• Asia-Pacific is expected to be the fastest-growing region at a CAGR of 10.6% from 2026 to 2033, fueled by improving healthcare infrastructure, increasing awareness of sudden cardiac arrest, expanding public AED deployment programs, and rising healthcare investments across China, India, Japan, and other emerging economies
• The automated external defibrillators (AEDs) segment led the market with a 39.5% share in 2025, driven by widespread deployment across hospitals, airports, schools, offices, sports facilities, and other public locations.
• Wearable external defibrillators are the fastest-growing product type, projected to register a CAGR of 11.0%, reflecting the surge in demand for continuous cardiac monitoring among patients at temporary risk of sudden cardiac arrest.
• The biphasic truncated exponential (BTE) waveform segment dominated the technology category with a 63.0% revenue share in 2025, led by its widespread adoption across automated external defibrillators and hospital-based emergency defibrillation systems.
• Hospitals & clinics accounted for 53.4% of the market share in 2025, preferred by the high volume of cardiac emergency cases requiring immediate defibrillation and advanced life-support interventions.
• The rectilinear biphasic waveform segment is the fastest-growing technology category, with a CAGR of 10.5%, driven by increasing adoption in advanced hospital defibrillators and emergency medical service applications.

Report Scope and Biphasic External Defibrillator Market Segmentation         

What is the Key Trend in the Biphasic External Defibrillator Market?

• Healthcare providers and public emergency response systems are increasingly adopting connected biphasic external defibrillators with real-time CPR feedback, cloud-based fleet management, and remote device monitoring to improve survival outcomes and operational readiness.
• or instance, in December 2025, the PulsePoint Foundation and ZOLL launched the "Anyone Can Register" initiative to accelerate growth of the National Emergency AED Registry (NEAR), encouraging volunteers, AED owners, and manufacturers to register AED locations and improve access during cardiac emergencies.
• Real-time CPR feedback and intelligent biphasic waveform technologies enable rescuers to deliver guideline-compliant chest compressions while optimizing shock effectiveness during sudden cardiac arrest resuscitation.
• Hospitals, emergency medical services, workplaces, and public institutions are leveraging connected AED ecosystems to improve device readiness, automate compliance monitoring, and enhance emergency response efficiency.
• For instance, in January 2025, researchers published a study titled "Public Access Defibrillator Deployment for Cardiac Arrests: A Learn-Then-Optimize Approach with SHAP-based Interpretable Analytics," introducing a machine learning-based framework that integrates SHAP analytics and optimization models to improve public access AED placement in high-risk locations.
• As healthcare systems continue prioritizing early defibrillation, digital connectivity, and public access defibrillation programs, adoption of advanced biphasic external defibrillators is expected to accelerate, reinforcing their role in modern emergency cardiac care.

What are the Key Drivers of the Biphasic External Defibrillator Market?

• The rising incidence of sudden cardiac arrest and cardiovascular diseases has significantly increased demand for biphasic external defibrillators capable of delivering rapid, effective, and evidence-based defibrillation therapy across healthcare and public settings.
• For instance, in June 2025, ZOLL Medical and Simon's Heart donated automated external defibrillators (AEDs) to 32 youth organizations across the U.S. through the "Anything Can Happen" campaign, expanding public access to life-saving biphasic external defibrillators and strengthening community cardiac emergency preparedness.
• Healthcare providers, emergency medical services, governments, and public organizations are expanding automated external defibrillator deployment to improve survival rates through earlier access to life-saving defibrillation.
• For instance, in February 2025, ZOLL Medical released findings showing that while 90% of Americans want a bystander to use an AED during a cardiac emergency, less than half feel responsible for doing so, reinforcing industry efforts to expand AED awareness and public access defibrillation programs.
• With healthcare systems increasingly emphasizing early defibrillation, public access AED programs, and evidence-based emergency response, biphasic external defibrillators will remain essential for improving survival following sudden cardiac arrest.

Which Factors are Challenging the Growth of the Next Generation Tobacco Products Market?

• The high acquisition, maintenance, battery replacement, electrode pad management, and regulatory compliance costs associated with biphasic external defibrillators continue to limit adoption, particularly across resource-constrained healthcare facilities and developing regions.
• For instance, in November 2025, AED NZ reported that recurring battery replacement, electrode pad replacement, and routine maintenance substantially increase the total cost of AED ownership, particularly for organizations managing large defibrillator fleets, creating a financial barrier to broader adoption.
• These ownership and lifecycle management costs create financial barriers for schools, small businesses, community organizations, and healthcare providers seeking to expand public access defibrillation programs.
• For instance, in December 2024, an investigation by the Houston Chronicle found that the AED at Marshall Middle School had expired electrode pads months before a student's cardiac emergency, highlighting how inadequate maintenance and consumable replacement can compromise device readiness and increase operational burdens for AED programs.
• The operational burden of periodic inspections, consumable replacement, software updates, and regulatory compliance further increases the total cost of ownership for external defibrillator fleets.
• These cost and maintenance requirements continue to slow market penetration in price-sensitive regions despite growing awareness of sudden cardiac arrest and increasing demand for public access defibrillation programs.

How is the Biphasic External Defibrillator Market Segmented?

The biphasic external defibrillator market is segmented on the basis of product type, technology, and end user.

• By Product Type

On the basis of product type, the biphasic external defibrillator market is segmented into automated external defibrillators (AEDs), manual external defibrillators, transcutaneous external defibrillators, and wearable external defibrillators. The automated external defibrillators (AEDs) segment dominated the market with a 39.5% revenue share in 2025, driven by widespread deployment across hospitals, airports, schools, offices, sports facilities, and other public locations. These devices are designed for use by both healthcare professionals and lay responders through automated voice and visual guidance, enabling rapid intervention during sudden cardiac arrest. Government initiatives promoting public access defibrillation programs and mandatory AED installations have significantly strengthened demand worldwide. Continuous innovations such as real-time CPR feedback, wireless connectivity, and automated self-testing capabilities are further improving device reliability and operational efficiency. Their portability, ease of operation, and compliance with international resuscitation guidelines make them the preferred product category globally. Growing awareness regarding early defibrillation and expanding emergency preparedness programs continue to reinforce the segment's market leadership.

The wearable external defibrillators segment is projected to register the fastest growth at an estimated CAGR of 11.0% from 2026 to 2033, driven by increasing demand for continuous cardiac monitoring among patients at temporary risk of sudden cardiac arrest. These wearable systems automatically detect life-threatening arrhythmias and deliver therapeutic shocks while allowing patients to continue normal daily activities outside hospital settings. Rising prevalence of cardiovascular diseases and growing preference for non-invasive cardiac protection are supporting market expansion. Technological advancements in lightweight wearable designs, wireless patient monitoring, and remote physician connectivity are enhancing clinical adoption. Increasing utilization as bridge therapy before implantable cardioverter defibrillator implantation is further accelerating demand. Expanding home healthcare services and personalized cardiac care are expected to sustain robust growth throughout the forecast period.

• By Technology

On the basis of technology, the global biphasic external defibrillator market is segmented into biphasic truncated exponential (BTE) waveform, rectilinear biphasic waveform, and others. The biphasic truncated exponential (BTE) waveform segment accounted for an estimated 63.0% market share in 2025, owing to its widespread adoption across automated external defibrillators and hospital-based emergency defibrillation systems. BTE technology delivers electrical shocks using lower energy levels while maintaining high defibrillation effectiveness, thereby minimizing myocardial injury compared with conventional monophasic technologies. Its proven clinical performance and extensive validation through international resuscitation guidelines have encouraged widespread adoption among healthcare providers. Leading manufacturers continue integrating BTE technology into their flagship defibrillator portfolios, strengthening market penetration. The technology also enables impedance-compensated shock delivery, improving treatment effectiveness across diverse patient populations. Its established clinical acceptance and strong manufacturer support continue to maintain technological leadership globally.

The rectilinear biphasic waveform segment is anticipated to witness the fastest growth at an estimated CAGR of 10.5% from 2026 to 2033, driven by increasing adoption in advanced hospital defibrillators and emergency medical service applications. This waveform delivers a constant current profile that enhances shock effectiveness across patients with varying thoracic impedance levels. Healthcare providers increasingly prefer rectilinear biphasic technology because of its consistent clinical performance during complex resuscitation procedures. Continuous product innovations integrating intelligent energy escalation, patient monitoring, and advanced resuscitation analytics are further supporting adoption. Rising investments in technologically advanced emergency care infrastructure are accelerating global demand. Ongoing clinical research validating optimized biphasic waveform performance is expected to further strengthen future growth.

• By End User

On the basis of end user, the global biphasic external defibrillator market is segmented into hospitals & clinics, emergency medical services (EMS), public access defibrillator (PAD), and home care settings. The hospitals & clinics segment dominated the market with a 53.4% revenue share in 2025, supported by the high volume of cardiac emergency cases requiring immediate defibrillation and advanced life-support interventions. Hospitals remain the primary purchasers of biphasic external defibrillators due to their established emergency departments, intensive care units, and specialized cardiac care centers. Increasing hospital admissions related to cardiovascular diseases and sudden cardiac arrest continue to drive equipment demand. Healthcare providers are also replacing aging defibrillator fleets with technologically advanced connected systems featuring CPR feedback and integrated patient monitoring. Continuous investments in emergency care infrastructure and compliance with international resuscitation standards further strengthen the segment. The availability of skilled healthcare professionals and comprehensive emergency response capabilities continues to reinforce hospital leadership.

The public access defibrillator (PAD) segment is projected to witness the fastest growth at an estimated CAGR of 10.8% from 2026 to 2033, driven by expanding public access defibrillation initiatives across airports, railway stations, schools, shopping malls, workplaces, and sports venues. Governments and healthcare organizations are increasingly investing in PAD programs to improve survival rates following out-of-hospital sudden cardiac arrest. Growing public awareness campaigns and mandatory AED installation regulations are encouraging wider deployment across public environments. Advances in user-friendly automated external defibrillators with voice prompts, cloud connectivity, and remote monitoring capabilities are making public adoption easier. Increasing collaboration between emergency medical services and community responders is improving emergency response times. Rising emphasis on community preparedness and early defibrillation is expected to drive sustained growth throughout the forecast period.

Which Region Holds the Largest Share of the Biphasic External Defibrillator Market?

• North America dominated the biphasic external defibrillator market with the largest revenue share of 41.9% in 2025, supported by a high prevalence of cardiovascular diseases, favorable public access defibrillation initiatives, and strong adoption of advanced emergency medical technologies.
• The region also benefits from favorable public access defibrillation initiatives, strong healthcare expenditure, increasing adoption of technologically advanced connected defibrillators, and the presence of leading manufacturers including ZOLL Medical, Stryker Corporation, and Philips. Growing awareness of early defibrillation, supportive resuscitation guidelines, and continued investments in emergency cardiac care infrastructure continue to strengthen North America's leadership position in the global market.

U.S. Biphasic External Defibrillator Market Insight

The U.S. biphasic external defibrillator market is witnessing strong growth due to the rising burden of sudden cardiac arrest (SCA), expanding public access defibrillation (PAD) programs, and continuous investments in emergency medical infrastructure. The country's well-established healthcare system, high adoption of automated external defibrillators (AEDs), and presence of leading manufacturers such as ZOLL Medical, Stryker, and Philips are driving market demand across hospitals, emergency medical services, and public settings. According to the American Heart Association, more than 356,000 out-of-hospital cardiac arrests occur annually in the U.S., with nearly 90% being fatal, reinforcing the importance of rapid AED access and early defibrillation. Increasing deployment of connected AEDs, supportive resuscitation guidelines, and growing community CPR-AED initiatives continue to accelerate market expansion.

Asia-Pacific Biphasic External Defibrillator Market Insight

The Asia-Pacific biphasic external defibrillator market is expected to witness rapid growth, driven by expanding healthcare infrastructure, rising cardiovascular disease prevalence, and increasing investments in emergency medical services across China, India, Japan, and Southeast Asia. Growing awareness regarding sudden cardiac arrest, increasing deployment of automated external defibrillators in public facilities, and improving emergency response capabilities are supporting regional market expansion. According to the World Health Organization, cardiovascular diseases remain the leading cause of death globally, with a substantial disease burden across Asia-Pacific, encouraging governments to strengthen emergency cardiac care infrastructure. In addition, increasing healthcare expenditure and wider adoption of advanced biphasic defibrillation technologies are further accelerating regional market growth.

Japan Biphasic External Defibrillator Market Insight

The Japan biphasic external defibrillator market is witnessing consistent growth due to an aging population, increasing incidence of cardiovascular diseases, and continued investments in advanced emergency healthcare technologies. Hospitals, emergency medical services, and public institutions are increasingly deploying automated external defibrillators to improve survival following sudden cardiac arrest. Japan has one of the world's most extensive public AED networks, with more than 600,000 AEDs installed nationwide, supporting rapid public access defibrillation and improved emergency response. Continuous emphasis on community preparedness, technological innovation, and high healthcare standards continues to strengthen market growth.

China Biphasic External Defibrillator Market Insight

The China biphasic external defibrillator market is growing rapidly, driven by expanding healthcare infrastructure, increasing government focus on emergency medical services, and growing awareness regarding sudden cardiac arrest. Rising installation of automated external defibrillators across airports, railway stations, schools, and commercial buildings is significantly boosting market demand. China has accelerated nationwide public AED deployment through the Healthy China 2030 initiative, with major cities including Shenzhen installing thousands of AEDs across public locations to strengthen emergency preparedness. Increasing healthcare investments and expanding public access defibrillation initiatives continue to position China among the fastest-growing regional markets.

U.K. Biphasic External Defibrillator Market Insight

The U.K. biphasic external defibrillator market is experiencing steady growth, supported by expanding public access defibrillation initiatives, increasing community awareness, and continuous investment in emergency cardiac care. The widespread deployment of automated external defibrillators across schools, transportation hubs, sports facilities, and workplaces is contributing to market growth. According to the British Heart Foundation, there are more than 30,000 defibrillators registered on The Circuit, the U.K.'s national defibrillator network, improving emergency access and response times. Government support, community engagement, and ongoing expansion of national AED registration programs continue to strengthen the U.K. market.

Germany Biphasic External Defibrillator Market Insight

The Germany biphasic external defibrillator market is expanding steadily due to the country's advanced healthcare infrastructure, strong emergency medical services network, and increasing adoption of technologically advanced defibrillation systems. Hospitals, ambulance services, and public institutions are continuously investing in modern biphasic external defibrillators to improve cardiac emergency outcomes. Germany continues to strengthen public access defibrillation through the German Resuscitation Council, which actively promotes AED availability and bystander resuscitation initiatives nationwide in line with the European Restart a Heart campaign. Continuous investments in emergency care infrastructure and resuscitation training are further supporting market growth.

Which are the Top Companies in Biphasic External Defibrillator Market?

The biphasic external defibrillator industry is primarily led by well-established companies, including:

• ZOLL Medical Corporation (U.S.)
• Stryker (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• NIHON KOHDEN CORPORATION (Japan)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• SCHILLER AG (Switzerland)
• A.M.I. ITALIA S.r.l. (Italy)
• Bexen Cardio (Spain)
• MEDIANA Co., Ltd. (South Korea)
• CU Medical System Co., Ltd. (South Korea)
• Progetti S.r.l. (Italy)
• BPL Medical Technologies (India)
• Defibtech, LLC (U.S.)
• HeartSine Technologies LLC (U.K.)
• GS Elektromedizinische Geräte G. Stemple GmbH (Germany)
• MS Westfalia GmbH (Germany)
• Silverline Meditech Pvt. Ltd. (India)
• Avive Solutions, Inc. (U.S.)
• Shenzhen XFT Medical Limited (China)
• Instramed Indústria Médico Hospitalar Ltda. (Brazil)

What are Latest Developments in Biphasic External Defibrillator Market?

• In December 2025, ZOLL Medical announced the launch of its fifth-generation LifeVest Wearable Cardioverter Defibrillator (WCD), incorporating a redesigned lightweight garment to improve patient comfort, wearability, and compliance while maintaining continuous protection against sudden cardiac arrest. The new product reflects ZOLL's continued innovation in wearable biphasic defibrillation technology for patients at temporary risk of life-threatening ventricular arrhythmias.
• In September 2025, ZOLL Medical received U.S. FDA premarket approval for its new Zenix Monitor/Defibrillator, a next-generation professional biphasic defibrillation system featuring Real CPR Help, Real BVM Help, a large touchscreen interface, and workflow automation for hospitals and emergency medical services. The product launch expands ZOLL's advanced resuscitation portfolio and enhances clinical decision-making, CPR quality, and emergency response efficiency in acute care settings.
• In January 2025, Philips announced the sale of its Emergency Care business to Bridgefield Capital, including its HeartStart automated external defibrillator portfolio. Under the agreement, Philips granted a long-term brand license to ensure the continued manufacturing, commercialization, and development of its emergency care and biphasic defibrillation products, supporting uninterrupted product availability in global markets.
• In October 2024, ZOLL Medical announced that its AED Plus automated external defibrillator received certification under the European Union Medical Device Regulation (EU MDR), enabling continued commercialization of the biphasic AED across European markets. The certification demonstrates compliance with updated regulatory and safety requirements while supporting broader deployment of public-access defibrillation systems throughout Europe.
• In February 2024, ZOLL Medical became one of the first manufacturers to achieve European Union Medical Device Regulation (EU MDR) certification for its automated external defibrillator portfolio. The certification reinforces the company's commitment to delivering compliant, high-quality biphasic defibrillation technologies while supporting continued product availability across European healthcare and public-access emergency response markets.

SKU-76562